Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim vs Placebo for Acute GvHD Prevention after Allogeneic BMT
NCT00207792Phase 3Unknown
- Sponsor
- Centre National de Greffe de Moelle Osseuse
- Start
- Jul 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in graft-versus-host disease (GVHD) comparing Filgrastim with Placebo (2 arms). Primary endpoint: Incidence of Acute Graft-versus-Host Disease. Status: unknown.
02
Drugs
filgrastim
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00207792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00207792.